(Q45250308)

11 December 2017

QT interval prolongation associated with the oral use of domperidone in an infant (English)

1 reference

11 December 2017

C M G Rocha

1

1 reference

PubMed ID

15690231

11 December 2017

M M Barbosa

series ordinal

2

1 reference

11 December 2017

1 September 2005

1 reference

11 December 2017

1 reference

11 December 2017

26

1 reference

11 December 2017

5

1 reference

11 December 2017

720-723

1 reference

https://scigraph.springernature.com/pub.10.1007/s00246-004-0922-z

11 December 2017

0 references

cites work

Cisapride-induced long QT interval

1 reference

12 December 2020

Gastroesophageal reflux disease in children: an overview of pathophysiology, diagnosis, and treatment

1 reference

12 December 2020

Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders

1 reference

12 December 2020

Q-T interval prolongation and ventricular fibrillation with i.v. domperidone

1 reference

12 December 2020

Domperidone: a peripherally acting dopamine2-receptor antagonist

1 reference

12 December 2020

Cardiac arrest after treatment with intravenous domperidone.

1 reference

12 December 2020

Gastroesophageal reflux in children. Clinical manifestations, diagnosis, and therapy.

1 reference

12 December 2020

TWO SUDDEN DEATHS DURING PROPHYLACTIC ANTIEMETIC TREATMENT WITH HIGH DOSES OF DOMPERIDONE AND METHYLPREDNISOLONE

1 reference

12 December 2020

Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone

1 reference

12 December 2020

Domperidone plus magnesium hydroxide and aluminum hydroxide: a valid therapy in children with gastroesophageal reflux. A double-blind randomized study versus placebo

1 reference

12 December 2020

Cardiotoxicity of domperidone

1 reference

12 December 2020

10.1007/S00246-004-0922-Z

Identifiers

DOI

1 reference

PubMed ID

15690231

Dimensions Publication ID

11 December 2017

0 references

1 reference

PubMed ID

15690231